Our Manila office opened in 2004, serving the third-largest pharmaceutical market in the ASEAN region. The Philippines is well positioned for future growth that will largely be driven by the government continuing to encourage the use of generics while improving the regulatory environment to attract foreign investment. In particular, clinical research into vaccinations used to prevent tropical diseases is an area that is bound to expand, due in part to the field having been neglected for many years and because of the availability of a large patient pool.
Health Expenditure per Capita
Source: World Health Organization Global Health Expenditure Database
Life Expectancy at Birth
Source: The World Fact Book;
Central Intelligence Agency
Clinical trial regulations in the Philippines: application and protocol approval
Clinical trial regulations in the Philippines are now of the utmost importance. The number of clinical trials conducted has increased substantially over the years. In 2009 alone, the Philippines saw a 30.9% increase in clinical trials conducted ...
Neglected tropical diseases and rabies: the struggles of the Philippine government
The Philippines has long been plagued by neglected tropical diseases (NTDs) such as schistosomiasis, soil-transmitted helminthiasis, leptospirosis, dengue and rabies. Poorer rural communities are disproportionally impacted ...
Manila OfficeRoom 400 Interior Office, 29th Floor, One Corporate Center, Meralco Ave. corner Julia Vargas Ave., Ortigas Center, Pasig City 1605, Philippines